In 2020, Merck Sharp & Dohme generated more than 13 billion yuan of revenue with its vaccine products in China. The company performed better than any other vaccine producers in the country, thanks to its highly effective 4-valent and 9-valent human papillomavirus (HPV) vaccines, priced at 798 yuan and 1,298 yuan respectively. The revenue of Sinopharm subsidiaries, including Beijing Institute of Biological Products, Shanghai Institute of Biological Products, and Chengdu Institute of Biological Products, was generated by the large production volumes of mostly Class I vaccines, which were universally covered by the mandatory and free vaccination programs of the Chinese government.
Leading vaccine manufacturers in China in 2020, based on total lot release contract price
(in billion yuan)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Frost & Sullivan. (March 9, 2022). Leading vaccine manufacturers in China in 2020, based on total lot release contract price (in billion yuan) [Graph]. In Statista. Retrieved November 18, 2024, from https://www.statista.com/statistics/1313659/china-leading-vaccine-manufacturers-based-on-lot-release-contract-price/
Frost & Sullivan. "Leading vaccine manufacturers in China in 2020, based on total lot release contract price (in billion yuan)." Chart. March 9, 2022. Statista. Accessed November 18, 2024. https://www.statista.com/statistics/1313659/china-leading-vaccine-manufacturers-based-on-lot-release-contract-price/
Frost & Sullivan. (2022). Leading vaccine manufacturers in China in 2020, based on total lot release contract price (in billion yuan). Statista. Statista Inc.. Accessed: November 18, 2024. https://www.statista.com/statistics/1313659/china-leading-vaccine-manufacturers-based-on-lot-release-contract-price/
Frost & Sullivan. "Leading Vaccine Manufacturers in China in 2020, Based on Total Lot Release Contract Price (in Billion Yuan)." Statista, Statista Inc., 9 Mar 2022, https://www.statista.com/statistics/1313659/china-leading-vaccine-manufacturers-based-on-lot-release-contract-price/
Frost & Sullivan, Leading vaccine manufacturers in China in 2020, based on total lot release contract price (in billion yuan) Statista, https://www.statista.com/statistics/1313659/china-leading-vaccine-manufacturers-based-on-lot-release-contract-price/ (last visited November 18, 2024)
Leading vaccine manufacturers in China in 2020, based on total lot release contract price (in billion yuan) [Graph], Frost & Sullivan, March 9, 2022. [Online]. Available: https://www.statista.com/statistics/1313659/china-leading-vaccine-manufacturers-based-on-lot-release-contract-price/
